|
注册号: Registration number: |
ChiCTR2300077732 |
|
最近更新日期: Date of Last Refreshed on: |
2024-06-18 17:18:01 |
|
注册时间: Date of Registration: |
2023-11-17 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
云南地区糖尿病性周围神经病变患病率、证型分布规律及影响因素的研究 |
|
Public title: |
Study on prevalence, pattern distribution and influencing factors of diabetic peripheral neuropathy in Yunnan Province |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
云南地区糖尿病性周围神经病变患病率、证型分布规律及影响因素的研究 |
|
Scientific title: |
Study on prevalence, pattern distribution and influencing factors of diabetic peripheral neuropathy in Yunnan Province |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
钱锐 |
研究负责人: |
钱锐 |
|
Applicant: |
Qian Rui |
Study leader: |
Qian Rui |
|
申请注册联系人电话: Applicant telephone: |
+86 138 8818 5640 |
研究负责人电话:
Study leader's |
+86 138 8818 5640 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
qr740220@sina.com |
研究负责人电子邮件: Study leader's E-mail: |
qr740220@sina.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
云南省昆明市五华区光华街120号 |
研究负责人通讯地址: |
云南省昆明市五华区光华街120号 |
|
Applicant address: |
120 Guanghua Street, Wuhua District, Kunming, Yunnan |
Study leader's address: |
120 Guanghua Street, Wuhua District, Kunming, Yunnan |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
云南省中医医院 |
||
|
Applicant's institution: |
Yunnan Provincial Hospital of Traditional Chinese Medicine |
||
|
研究负责人所在单位: |
云南省中医医院 |
||
|
Affiliation of the Leader: |
Yunnan Provincial Hospital of Traditional Chinese Medicine |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
YL[2023]伦审字(009)-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
云南省中医医院 医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Yunnan Provincial Hospital of Traditional Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-06-26 00:00:00 | ||
|
伦理委员会联系人: |
马军 |
||
|
Contact Name of the ethic committee: |
Ma Jun |
||
|
伦理委员会联系地址: |
云南省昆明市西山区西园路48号 |
||
|
Contact Address of the ethic committee: |
48 Xiyuan Road, Xishan District, Kunming, Yunnan |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 871 6363 5609 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
ynszyyylunli@126.com |
|
研究实施负责(组长)单位: |
云南省中医医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Yunnan Provincial Hospital of Traditional Chinese Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
云南省昆明市五华区光华街120号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
120 Guanghua Street, Wuhua District, Kunming, Yunnan |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家中医优势专科建设项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
National TCM Advantage Specialty Construction Project |
||||||||||||||||||||||
|
研究疾病: |
糖尿病周围神经病变 |
||||||||||||||||||||||
|
Target disease: |
Diabetic peripheral neuropathy |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
开展云南地区多中心糖尿病患者DPN现况调查,有利于扩大DPN知晓率,有利于推广规范DPN筛查方法,提高患者DPN的检出率,促进DPN规范治疗。开展云南地区多中心糖尿病患者DPN现况调查,对云南地区糖尿病性周围神经病变患者病例资料进行整理分析,总结中医常见证型及证型分布规律,探讨不同证型与理化指标等因素的相关性,可为临床诊疗提供更多的辨治思路。总之,开展云南地区多中心糖尿病患者DPN现况调查,旨在为糖尿病DPN的早期诊断和早期干预提供科学依据,以提高糖尿病患者并发症的总体管理水平。 |
||||||||||||||||||||||
|
Objectives of Study: |
To investigate the status of DPN in multi-center diabetic patients in Yunnan is conducive to expanding DPN awareness rate, promoting standardized DPN screening methods, improving the detection rate of patients with DPN, and promoting standardized DPN treatment. The DPN status of multi-center diabetic patients in Yunnan region was investigated, the case data of diabetic peripheral neuropathy patients in Yunnan region were sorted out and analyzed, the distribution rules of TCM common witness types and syndrome types were summarized, and the correlation between different syndrome types and physical and chemical indexes was discussed, which could provide more differentiation and treatment ideas for clinical diagnosis and treatment. In conclusion, the current status of DPN in multi-center diabetic patients in Yunnan was investigated to provide scientific basis for early diagnosis and intervention of diabetic DPN, so as to improve the overall management level of complications in diabetic patients. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.其他原因引起的神经病变,如颈腰椎病变(神经根压迫、椎管狭窄、颈腰椎退行性变)、脑梗死、吉兰-巴雷综合征; 2.严重动静脉血管性病变(静脉栓塞、淋巴管炎)等; 3.化疗药物引起的神经毒性作用以及肾功能不全引起的代谢毒物对神经的损伤; 4.妊娠或者哺乳期妇女; 5.精神疾病患者; 6.不能配合DPN体征检查患者; 7.患者不能配合或者研究者认为不适合参加的。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Neuropathy caused by other causes, such as cervical and lumbar spine lesions (nerve root compression, spinal stenosis, cervical and lumbar degenerative changes), cerebral infarction, Guillain-Barre syndrome; 2. Severe arteriovenous vascular diseases (venous embolism, lymphangitis), etc.; 3. Neurotoxic effects caused by chemotherapy drugs and damage to nerves caused by metabolic poisons caused by renal insufficiency; 4. Pregnant or lactating women; 5. Patients with mental illness; 6. Patients who cannot cooperate with DPN physical examination; 7. Patients can not cooperate or researchers think it is not suitable to participate. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-12-01 00:00:00至 To 2025-11-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-12-01 00:00:00 至 To 2025-11-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
采用各中心随机抽样法。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The method of random sampling by each center was adopted. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
使用自制问卷进行数据采集,录入SPSS进行数据管理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Self-made questionnaires were used for data collection and input into SPSS for data management. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |